214 related articles for article (PubMed ID: 35681422)
21. Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model.
Lakomá J; Rimondini R; Ferrer Montiel A; Donadio V; Liguori R; Caprini M
Mol Pain; 2016; 12():. PubMed ID: 27531673
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of ASIC1a channels in an in vitro model of Fabry disease.
Castellanos LCS; Rozenfeld P; Gatto RG; Reisin RC; Uchitel OD; Weissmann C
Neurochem Int; 2020 Nov; 140():104824. PubMed ID: 32841711
[TBL] [Abstract][Full Text] [Related]
23. Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
Sueoka H; Aoki M; Tsukimura T; Togawa T; Sakuraba H
PLoS One; 2015; 10(12):e0144958. PubMed ID: 26661087
[TBL] [Abstract][Full Text] [Related]
24. The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
Mallett A; Kearey P; Cameron A; Healy H; Denaro C; Thomas M; Lee VW; Stark S; Fuller M; Hoy WE
BMC Nephrol; 2020 Feb; 21(1):58. PubMed ID: 32087678
[TBL] [Abstract][Full Text] [Related]
25. Generation of
Song HY; Chien CS; Yarmishyn AA; Chou SJ; Yang YP; Wang ML; Wang CY; Leu HB; Yu WC; Chang YL; Chiou SH
Cells; 2019 Apr; 8(4):. PubMed ID: 30965672
[TBL] [Abstract][Full Text] [Related]
26. Nationwide screening for Fabry disease in unselected stroke patients.
Tomek A; Petra R; Paulasová Schwabová J; Olšerová A; Škorňa M; Nevšímalová M; Šimůnek L; Herzig R; Fafejtová Š; Mikulenka P; Táboříková A; Neumann J; Brzezny R; Sobolová H; Bartoník J; Václavík D; Vachová M; Bechyně K; Havlíková H; Prax T; Šaňák D; Černíková I; Ondečková I; Procházka P; Rajner J; Škoda M; Novák J; Škoda O; Bar M; Mikulík R; Dostálová G; Linhart A;
PLoS One; 2021; 16(12):e0260601. PubMed ID: 34905550
[TBL] [Abstract][Full Text] [Related]
27. Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy.
Liguori R; Incensi A; de Pasqua S; Mignani R; Fileccia E; Santostefano M; Biagini E; Rapezzi C; Palmieri S; Romani I; Borsini W; Burlina A; Bombardi R; Caprini M; Avoni P; Donadio V
PLoS One; 2017; 12(7):e0180581. PubMed ID: 28672034
[TBL] [Abstract][Full Text] [Related]
28. Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease.
Kaneski CR; Hanover JA; Schueler Hoffman UH
Mol Genet Metab Rep; 2022 Dec; 33():100914. PubMed ID: 36092250
[TBL] [Abstract][Full Text] [Related]
29. Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect.
Park JL; Whitesall SE; D'Alecy LG; Shu L; Shayman JA
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1156-63. PubMed ID: 18565198
[TBL] [Abstract][Full Text] [Related]
30. Gene Expression Analysis in
Elsaid HOA; Tjeldnes H; Rivedal M; Serre C; Eikrem Ø; Svarstad E; Tøndel C; Marti HP; Furriol J; Babickova J
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613802
[TBL] [Abstract][Full Text] [Related]
31. Ceria-Zirconia nanoparticles reduce intracellular globotriaosylceramide accumulation and attenuate kidney injury by enhancing the autophagy flux in cellular and animal models of Fabry disease.
An JH; Hong SE; Yu SL; Kang J; Park CG; Lee HY; Lee SK; Lee DC; Park HW; Hwang WM; Yun SR; Park Y; Park MH; Yoon KR; Yoon SH
J Nanobiotechnology; 2022 Mar; 20(1):125. PubMed ID: 35264192
[TBL] [Abstract][Full Text] [Related]
32. GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
Chaves-Markman ÂV; Markman M; Calado EB; Pires RF; Santos-Veloso MAO; Pereira CMF; Lordsleem ABMDS; Lima SG; Markman Filho B; Oliveira DC
Arq Bras Cardiol; 2019 Jul; 113(1):77-84. PubMed ID: 31291414
[TBL] [Abstract][Full Text] [Related]
33. Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases.
Belfiore MP; Iacobellis F; Acampora E; Caiazza M; Rubino M; Monda E; Magaldi MR; Tarallo A; Sasso M; De Pasquale V; Grassi R; Cappabianca S; Calabrò P; Fecarotta S; Esposito S; Esposito G; Pisani A; Pavone LM; Parenti G; Limongelli G
PLoS One; 2020; 15(5):e0233050. PubMed ID: 32428018
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Novel GLA Gene Mutation, p.Ile239Met, in Fabry Disease With a Predominant Cardiac Phenotype.
Csányi B; Hategan L; Nagy V; Obál I; Varga ET; Borbás J; Tringer A; Eichler S; Forster T; Rolfs A; Sepp R
Int Heart J; 2017 May; 58(3):454-458. PubMed ID: 28496025
[TBL] [Abstract][Full Text] [Related]
35. Generation of an
Kaneski CR; Hanover JA; Schueler Hoffman UH
Mol Genet Metab Rep; 2022 Jun; 31():100871. PubMed ID: 35782611
[TBL] [Abstract][Full Text] [Related]
36. Age-related neuroimmune signatures in dorsal root ganglia of a Fabry disease mouse model.
Choconta JL; Labi V; Dumbraveanu C; Kalpachidou T; Kummer KK; Kress M
Immun Ageing; 2023 May; 20(1):22. PubMed ID: 37173694
[TBL] [Abstract][Full Text] [Related]
37. Fabry disease: GLA deletion alters a canonical splice site in a family with neuropsychiatric manifestations.
Varela P; Carvalho G; Martin RP; Pesquero JB
Metab Brain Dis; 2021 Feb; 36(2):265-272. PubMed ID: 33156427
[TBL] [Abstract][Full Text] [Related]
38. Generation of a GLA knock-out human-induced pluripotent stem cell line, KSBCi002-A-1, using CRISPR/Cas9.
Kim YK; Yu JH; Min SH; Park SW
Stem Cell Res; 2020 Jan; 42():101676. PubMed ID: 31841972
[TBL] [Abstract][Full Text] [Related]
39. Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
Namdar M; Gebhard C; Studiger R; Shi Y; Mocharla P; Schmied C; Brugada P; Lüscher TF; Camici GG
PLoS One; 2012; 7(4):e36373. PubMed ID: 22558451
[TBL] [Abstract][Full Text] [Related]
40. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
Rosa Neto NS; Bento JCB; Pereira RMR
Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
